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Objective. To report the irreversible severe neurological symptoms following the hyponatremic hypertensive syndrome (HHS)
in an infant after umbilical arterial catheterization. Design. Case report with review of the literature. Setting. Neonatal intensive
care unit at a tertiary care children’s hospital. Patient. A three-week-old preterm infant. Conclusions. In evaluating a neonate with
hyponatremia and hypertension, HHS should be considered, especially in case of umbilical arterial catheterization. In case of
diagnostic delay, there is a risk of severe irreversible neurological damage.
1.Introduction
In the neonatal intensive care unit (NICU) population, hyp-
onatremia is the most frequent encountered water and salt
abnormality.With itsbroaddiﬀerentialdiagnosis, itprovides
a challenge to the neonatologist. The most frequent causes
are renal salt loosing through an immature kidney and the
use of drugs such as diuretics [1]. Hypertension, however,
is a relatively rare feature in children, especially in neonates,
with an incidence in NICU’s ranging from 0.7% to 3.2%,
and renal arterial thrombosis following umbilical arterial
catheterization as the leading cause [2, 3].
A rare clinical presentation of unilateral renal arterial
stenosis is the hyponatremic hypertensive syndrome (HHS),
characterized by activation of the renin angiotensin aldos-
terone (RAAS)system in the ischemic kidney,causing hyper-
tension, and a counteracting eﬀect on the other kidney, by
diﬀerent mechanisms leading to volume depletion and loss
of electrolytes. This syndrome is caused by unilateral renal
ischemia, due to stenosis or o c c l u s i o no fa( b r a n c ho fa )
renal artery, and also occurs in a variety of other underlying
disorders [4]. So far, only a few reports of HHS in children
are available, with polydipsia, polyuria, enuresis, weight loss,
volume depletion, and various neurological and behavioural
symptoms as presenting symptoms [5].
We present a case of HHS in a preterm infant, with an
extremely low sodium concentration, and discuss the dif-
ﬁculties encountered intreatment and the irreversible neuro-
logical sequels due to this potentially life-threatening meta-
bolic disturbance.
2.Case Report
A preterm boy presented with extreme hyponatremia (plas-
ma sodium of 101mmol/L) at the 20th day after birth. He
was born from a nulliparous woman at a gestational age
of 31 weeks and 4 days after an uncomplicated pregnan-
cy, followed by spontaneous rupture of membranes and
antenatal corticosteroid administration. Apgar scores were 9
and 10 at 1 and 5 minutes, and the birth weight was 2080
grams. There were no complications during NICU stay over
the ﬁrst 3 days of life. An umbilical arterial catheter was
inserted directly after birth, for the purpose of blood press-
ure monitoring, and removed after 3 days. Furthermore2 International Journal of Nephrology
an umbilical venous catheter and subsequently a peripheral
central venous catheter were inserted for the purpose of par-
enteralfeeding. Routinecerebralultrasonography showed an
image consistent with the gestational age and mild periven-
tricular ﬂaring. No diuretics were administered.
A tt h et h i r dd a yo fl i f et h eb o yw a st r a n s f e r r e di ng o o d
clinical condition to a regional hospital. He gained weight
(from 1900 grams at the 3rd day to 2100 grams at two weeks
after birth). At the age of 3 weeks rejection to feeding (until
this moment consisting of 150mL/kg/day breast milk with
breast milk fortiﬁer), weight loss (to a minimum of 1960
grams),irritability,hyperthermia,andpolyuriawerenoticed.
Cerebrospinal ﬂuid analysis showed 219leukocytes/mm3
with 12000erythrocytes/mm3, after a traumatic lumbar
puncture, thus a meningitis could no be excluded and intra-
venous antibiotics were started. Intravenous ﬂuids, with a
total volume of 150mL/kg/day, containing 8mg/kg/min glu-
cose and 5mmol/kg/day sodium, were administered in the
regional hospital for 2 days (before return to the NICU).
The plasma sodiumlevelhad declined,from 140mmol/L
nine days before, to 101mmol/L. There were no sodium lev-
els examined in the interval between, but the level at the
onset of symptoms was established at 112mmol/L retrospec-
tively in plasma stored at the laboratory of the regional hos-
pital. The boy returned to the NICU under suspicion of a
syndrome of inappropriate antidiuretic hormone secretion
(SIADH) associated with the assumed meningitis, with initi-
ated ﬂuid restriction and sodium supplementation consid-
ered to be the appropriate therapy. The body weight at that
time was 2030 grams.
We saw a pale, irritated neonate with tachypnea, arterial
hypertension (104/60mmHg, mean 78mmHg), opisthoto-
nus,andabnormalsynchronized extensions ofarms andlegs.
Additional to the plasma sodium level of 101mmol/L, labo-
ratory analysis revealed a mild hypokalemia, hypochloremia,
and hypomagnesemia, with normal calcium and phosphate
levels (for detailed information on all important laboratory
results, see Table 1). Plasma osmolarity was 219mOsmol/kg,
and urea and creatinine levels were normal. Blood gas anal-
ysis showed a respiratory alkalosis with normal bicarbonate.
Infection parameters were low, but liver enzymes and lac-
tate were elevated (in the blood drawn several shortly after
the seizure). Furthermore an elevated plasma B-type natri-
uretic peptide (BNP) of1228pmol/L was found (in children,
there are no validated data on normal values available). Uri-
nalysis showed no leucocytes, mild hematuria, low sodium
and potassium, with proteinuria, glucosuria, and a urine os-
molarity of129mOsmol/kg.Culturesofblood,urine and ce-
rebrospinal ﬂuid revealed no microorganisms.
The combination of hyponatremia and hypertension
(deﬁned as a mean blood pressure of >2 standard deviations
for age and weight, in this case >75mmHg) was suggestive
of renal pathology. Abdominal Doppler ultrasound showed
a right renal arterial thrombosis, partially calciﬁed, and an
oedematous appearance of the left kidney. It was suggested
that the symptoms of this neonate resulted from an HHS
secondary to a renal arterial thrombosis.
Blood pressure levels further increased in the ﬁrst hours
to a maximum of 108/62 (mean 96)mmHg. We chose to
Table 1: Laboratory values in plasma and urine, measured in the
patient at readmission to the NICU.
Laboratory measurement Measured value Normal values
Plasma
Sodium (mmol/L) 101 136–146
Potassium(mmol/L) 3.0 3.4–6.0
Chloride (mmol/L) 70 99–108
Magnesium (mmol/L) 0.66 0.70–1.00
Calcium, ionized (mmol/L) 1.25 0.95–1.50
Phosphate (mmol/L) 1.26 1.25–2.10
Glucose (mmol/L) 6.4 3.6–5.6
Osmolarity(mOsmol/kg) 219 280–295
Urea (mmol/L) 3.4 3.0–7.5
Creatinine (µmol/L) 44 27–62
pH (arterial blood) 7.56 7.37–7.4
pCO2 (mmHg) 26 35–45
Bicarbonate (mmol/L) 22.9 22–28
Base excess (mmol/L) 1.0 −3.0–3.0
Lactate (mmol/L) 3.6 0.0–2.2
BNP (pmol/L) 1228 (Adult) <30–120
Hb (mmol/L) 8.4 (Adult) 5.9–8.4
Ht (mmol/L) 0.34 0.41–0.50
Erythrocytes (×1012/L) 3.94 3.20–4.80
Urine
Sodium (mmol/L) <10 Not available
Potassium(mmol/L) 19 Not available
Glucose (mmol/L) 16.1 Not available
Osmolarity(mOsmol/kg) 129 Not available
Protein (g/L) >2.0 Not available
Creatinine (mmol/L) 1.5 Not available
pH 7.0 4.5–8.0
Erythrocytes (per µL) 60 0–10
carefully normalise the blood pressure with intravenous di-
hydralazine, causing the right kidney to become completely
afunctional (as demonstrated with 99m technetium MAG3
renography in combination with the ﬁndings on Doppler
ultrasound as mentioned before). Furthermore we supple-
mented sodium (by intravenous sodium chloride). Plasma
sodium levels rose to, relatively fast within the ﬁrst hours,
above120mmol/L,andmoreslowlywithin thenext24hours
to normal. The dihydralazine and sodium supplementation
could be gradually stopped after a few days, after which a
normalbloodpressureandelectrolytelevelsweremaintained
without any additional therapy, also urinalysis returned to
normal.
Within a few minutes after return to the NICU the boy
developed convulsions, successfully treated with phenobar-
bital. Cerebral ultrasound and magnetic resonance imaging
(MRI) showed extensive white matter abnormalities and
the presence of a sinus thrombosis of the superior sagittal,
straight, and transverse sinus. Additional genetic screening
revealed a mutation in the methylenetetra-hydrofolate re-













Figure 1: Suggested pathophysiology of the hyponatremic hypertensive syndrome, based on data from Nicholls 2006 [5].
Follow-up MRI at one and two months of age showed
extension of the white matter abnormalities, with secondary
haemorrhage, vacuolisation, and cyst formation. The gyra-
tion and myelinisation had increased, there were no signs
of new ischemia, and all sinuses were recanalized. The child
showed abnormal neurological behaviour (agitation, uncon-
trolled movements, and delayed motor development) at
three monthsoffollowup.The parents ofthischild gavetheir
informed consent to publication of this case report.
3.Discussion
In this case report, we describe a 3-week-old preterm boy,
with extreme hyponatremia, hypertension and a dramatic
neurologicaloutcome,asaresultofHHSfollowing umbilical
arterial catheterization.
The typical combination of symptoms in HHS was ﬁrst
described in 1952in adults[6], and the term HHS was estab-
lished by Brown et al. in 1965 [4]. The majority of adult
patients are elderly women with atherosclerosis [7]. In chil-
dren, the syndrome is not encountered frequently and in
neonates it is even more rare, with renal arterial steno-
sis following umbilical arterial catheterization being one of
the described causes [8–10], accompanied by renal micro-
thrombi in sepsis [11] and an association with Dexametha-
soneuse[7].Thesyndrome hasbeendescribedmoreoftenin
preterm than in term infants [8–11] and sometimes showed
al e t h a lc o u r s e[ 12, 13]. The high incidence of hyponatremia
(30%) reported in hypertensive neonates, suggests that HHS
is probably more common than we think [14].
HHS is thought to be due to a complex interplay of dif-
ferent mechanisms, with unilateral renal hypoperfusion and
a counteracting eﬀect of the contralateral normal kidney as
major hallmarks (“two-kidney-one-clip hypertension”) [12]
(Figure 1). The renal arterial thrombosis causes hypoperfu-
sion of one kidney, which activates the RAASsystem to cause
hypertension. The contralateral nonstenotic kidney reacts
to this hypertension by excreting water and sodium (press-
ure diuresis and natriuresis) [12, 15]. The hypertension
additionally stimulates the cardiac atrial natriuretic peptide
(ANP) and BNP to excrete more sodium and protein [16].
Theresultinghypovolemia,probablytogetherwithanin-
creased production of angiotensin II, stimulates antidiuretic
hormone (ADH), further aggravating the hyponatremia.
Furthermore, aldosterone causes renal potassium loss, which
in turn stimulates renin secretion, causing a vicious circle
[15]. Proteinuria, glucosuria, and hypercalciuria can also be
present due to glomerular hyperﬁltration in hypertension,
increased renin activity, and probably even more extensive
tubulointerstitial involvement [17].
In our case, the presence of an umbilical arterial catheter,
and theﬁnding ofa mutationin theMTHFRgene(suggested
to play role in homocysteine metabolism and enhancing
atherosclerosis) were thought to be contributing factors in
the developmentof the renal arterial thrombosis. At the mo-
ment of presentation at the NICU, our patient was thought
to be already beyond the natriuretic phase of HHS (probably
the severe hyponatremia ﬁnally resulted in sodium retention,
explaining the low urine sodium) and most likely ADH had
been turned on in reaction to the volume depletion. The
initial sepsis-likepresentationwasretrospectively interpreted
as the result of a combination of hypovolemia and central
nervous system disturbances.
The prematurity was probably a major contributing
factor leading to the severe outcome in this patient. This
could have led to more extreme hyponatremia because pret-
erms have a relatively low sodium intake, reduced tubular
sodium reabsorption, and decreased glomerular ﬁltration
rate, impairing free water excretion [18]. Furthermore, rec-
ognizing the nonspeciﬁc clinical symptoms of HHS can be
very diﬃcult in a neonate. This diagnostic delay can result in
long-lasting untreated hyponatremia and hypertension.
The symptoms of HHS disappeared after normalising
the blood pressure with a vasodilator agent (dihydralazine),
causingtheischemickidneytobecomenonvitalbytotallyab-
rogating theblood ﬂow, destroying thejuxtaglomerularcells,
and hence stopping renin production. There was a gradu-
al decline in blood pressure in this patient, diﬀerent from
the potentially dangerous fall which can be seen with angiot-
ensin-converting enzyme (ACE) inhibitors [19]. With severe
volume depletion, cautious repletion is needed, which can
probably also reduce arterial pressure by suppression of
RAAS [20].4 International Journal of Nephrology
Correction of longstanding hyponatremia should be
managed carefully, to minimise the risk of developing cere-
bral shrinking [21]. Final therapy of the underlying renal
arterial stenosis was not necessary in this case, but can be
achieved by balloon angioplasty, renal artery stenting, or
uninephrectomy. However, in small children the ﬁrst men-
tioned options can be technically impossible.
The remarkable irreversible neurological features in this
case are most likely to be the consecutive eﬀect of a hyper-
tensive and hyponatremic encephalopathy, aggravated by a
diminished cerebral circulation due to hypovolemia and a
sinus thrombosis. Furthermore the convulsions could also
have led to irreversible damage to the vulnerable preterm
brain. Previous case reports in older children mainly men-
tion reversible neurological symptoms, and even reversible
ﬁndings on computer tomography or MRI associated with
HHS [19, 22–24] and only one infant dying from massive
cerebral haemorrhage [13].
Werealisethattherearefewlimitationsinthedescription
of this case. First, there is a lack of (clinical and laboratory)
information about the period before the patient represented
with the severe hyponatremia. Unfortunately, no detailed in-
formation on water balance or 24-hour urine volumes dur-
ing the period in which the patient developed the hypona-
tremia wasavailable.Asitisespecially cumbersometocollect
such data in newborns, this is very rarely done. Second, no
data on plasma ADH, rennin, and aldosterone are available
to conﬁrm our suggested diagnosis.
This case was meant to describe the complex pathophys-
iology of HHS, and the possible misleading clinical features
in a neonate. Furthermore we want to underline the risk of
severe irreversible neurological damage when there is a diag-
nostic delay. We think that in evaluating a neonate with
severe hyponatremia, HHS should be considered, especially
if following umbilical arterial catheterization.
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